Expert treatment from our team of dedicated gynecologic cancer specialists.

Make the best decisions about your cancer care with unmatched expertise from MedStar Health's top-ranked gynecologic oncologists.

When you are diagnosed with cancer, your world turns upside down. But your family, friends, and colleagues depend on you. You need an accurate diagnosis, the best treatment, and the most efficient care from providers who can get you back to your busy life.

Whether you are newly diagnosed, had an abnormal Pap smear, or are seeking a second opinion, you won’t have to wait to get answers and peace of mind.

MedStar Health Cancer Network medical and surgical oncologists bring the most advanced gynecologic cancer innovations close to home. With the latest treatments and technologies at our fingertips, you’ll get personalized care from nationally recognized experts who take the time to understand you and your unique situation.

We offer second-opinion appointments within 48 hours. Get the answers and support you need, close to home, with MedStar Health Cancer Network in Baltimore.

To make an appointment call

443-777-7990,
Request an Appointment

At MedStar Health Cancer Network, you will get:

Convenient access to cancer experts.

All the board-certified providers on your care team can communicate easily—together and with you—through our secure electronic health records system. We want to know what matters most to you. With convenient locations throughout the Baltimore area, we are always available to answer your questions. Meet the gynecologic cancer team.

To make an appointment call

443-777-7990,
Request an Appointment

Expert information about your type of cancer.

When you are first diagnosed, you and your family will have a lot of questions. We will guide you through finding the answers. Start with the information below about your cancer type, and jot down questions to ask when you visit with our team.
  • Uterine or endometrial cancer

    Uterine (endometrial) cancer is the most common type of cancer we see—more than 67,000 patients develop uterine cancer each year. However, it is generally highly curable since it is often caught early.

    There are three types of uterine cancer:

    • Estrogen-sensitive, which is related to obesity and diabetes
    • Genetic or environmental, which is more aggressive and typically occurs in older patients. Approximately 2-3% of uterine cancers are associated with Lynch syndrome, a common genetic mutation. All MedStar Health Cancer Network patients with uterine cancer receive genetic testing.
    • Sarcoma, an aggressive, soft-tissue tumor. African-American patients are more prone to develop sarcomas, which can be more difficult to treat.
    Uterine cancer is typically treated with robotic surgery. Immunotherapy is now a standard of care for advanced stage uterine cancer. Pembrolizumab (Keytruda) helps boost the body’s immune response to cancer. The targeted drug lenvatinib (Lenvima) can be added to detect and destroy uterine cancer cells.
  • Ovarian cancer

    Though fewer than 25,000 patients are diagnosed with ovarian cancer each year, it causes approximately half of deaths due to gynecologic cancer. Approximately 75% of cases are diagnosed at an advanced stage. There is currently no standard screening for ovarian cancer.

    Ovarian cancer causes symptoms that can be easily mistaken for gastrointestinal issues, such as bloating or indigestion. However, if these symptoms last for a few weeks, visit your doctor for a pelvic exam and ultrasound.

    Ovarian cancer can be hereditary. Many gene mutations, such as BRCA1 and BRCA2, are associated with ovarian cancer, so we recommend patients visit with a genetic counselor.

    Epithelial ovarian cancer is the most common type, arising from cells in the lining of the ovaries. Ovarian cancer can also arise from the fallopian tubes, abdominal lining (peritoneal), or germ cells (pre-egg cells), or granulosa cells that produce estrogen (usually in younger women).

    New, innovative treatment options:

    • Hyperthermic intraperitoneal chemotherapy (HIPEC), in which the abdomen is filled with medication to destroy tumors.
    • Immunotherapy, which uses the body’s immune system to eliminate cancer cells.
    • PARP-inhibitor maintenance therapy, which prevents cancer cells from repairing themselves.
  • Cervical cancer

    The cervix is the tissue between your uterus and vagina, which the doctor checks during a Pap smear. If cells collected for the smear look abnormal, the gynecologist will refer you to be checked for cancer.

    Getting an annual women’s health exam can help patients avoid cervical cancer or catch it early, when it is most treatable. Pre-cancerous cells and small tumors can be removed with surgery. Advanced cervical cancers typically require chemotherapy and/or radiation therapy.

    Fewer than 20,000 women in the U.S. develop cervical cancer each year. It is not hereditary and is not caused by estrogen. Cervical cancer is the only cancer shown to be caused by a virus, the human papillomavirus (HPV). While HPV infection is harmless in most patients, in some it leads to cervical cancer. With the development of the HPV vaccine, there is the potential to one day eradicate cervical cancer.
  • Vaginal and vulvar cancer

    The vulva is the outside of the genital area, and the vagina is the inside. These cancers typically appear as lesions on the skin or inside the vagina. Both are related to HPV and lifestyle choices, such as smoking.

    Vaginal and vulvar cancers are rare, with fewer than 10,000 cases diagnosed each year. MedStar Health Cancer Network sees many patients with an abnormal Pap smear after hysterectomy or vaginal or vulvar dysplasia (VAIN or VIN), which are lesions or skin changes that are suspicious for cancer.

    Vaginal and vulvar cancer treatment usually involves surgery, along with sentinel lymph node tracking, chemotherapy, and/or radiation.
  • Pregnancy cancers

    Molar pregnancies or (gestational trophoblastic disease) are a very rare condition in which a patient has a miscarriage and the placenta remains, developing invasive cancer cells. Treatment typically involves chemotherapy.

    Rarely, a patient who is pregnant may have another type of gynecologic cancer. MedStar Health Cancer Network has the expertise and technology to treat these patients and seek the best possible outcomes for their pregnancies.

Advanced, innovative treatment options.


Swift, personalized treatment leads to quicker, potentially more successful outcomes. We use the most advanced technology to diagnose and stage your cancer.

At our academic medical center, you will have access to cutting-edge, world-class treatment options that are not widely available, including:
  • Advanced chemotherapy: Refined, closely monitored chemo can effectively destroy cancer cells throughout the body, alone or in combination with surgery.
  • Clinical trials: Get the highest standard of care plus access to the latest, most promising therapies that are only available through clinical trials at specialized cancer centers such as MedStar Health Cancer Network.
  • Hyperthermic intraperitoneal chemotherapy (HIPEC): The abdomen is temporarily filled with chemotherapy medication to destroy tumors.
  • Immunotherapy: This innovative therapy trains your body's immune system to recognize, surround and destroy cancer cells.
  • Lymph node tracing: Using a special dye, we can determine whether a gynecologic cancer has spread to the lymph nodes. We can remove affected lymph nodes, improving patient outcomes.
  • Minimally invasive cancer surgery: Advanced techniques such as robotic surgery give patients exceptional results with less pain, scarring, and recovery time than traditional surgery.
  • Targeted radiation therapy: Highly focused radiation techniques can effectively shrink tumors and destroy cancer cells in fewer, less invasive treatments.
  • Fertility and hormone therapy: Women who want to have children after cancer treatment may have options for fertility-sparing procedures and egg harvesting. We work closely with reproductive endocrinologists to determine the safest, most effective options to preserve fertility and balance the hormones while treating your cancer.

To make an appointment call

443-777-7990,
Request an Appointment

Facebook Live: Gynecologic Cancers

play button
In honor of #GynecologicCancerAwarenessMonth, we sat down with Dr. John McBroom, gynecologic oncologist, discussing the different types of gynecologic cancers such as cervical, ovarian, uterine/endometrial, vaginal, and more. Tune in to learn more about their risk factors, symptoms, treatment options.

Expert cancer team. Exceptional results.


Our specialists from MedStar Health Cancer Network are internationally recognized in cancer research, diagnosis, and treatment. We are consistently named "Top Docs" by Baltimore magazine. Our award-winning team holds Accreditation with Commendation, the highest level of approval from the American College of Surgeons' Commission on Cancer.

Every patient benefits from the collective expertise of our multidisciplinary team, which meets weekly to review every patient's case. We combine our skills so you get the best care for your unique needs. Meet your cancer care team.

Charles Russel Boice, MD
Gynecologic Oncologist

John Warren McBroom, MD
Gynecologic Oncologist

Shweta Kurian, MD
Medical Oncologist

Kelly Orwat, MD
Radiation Oncologist

Kamila A. Nowak-Choi, MD
Radiation Oncologist

Kai A. Andrews, MS, CRNP, FNP-C
Nurse Practitioner

Emily Kuchinsky
Certified Genetic Counselor

Visit us close to where you live and work.

MedStar Franklin Square Medical Center

9103 Franklin Square Dr.
Suite 2200
Baltimore, MD 21237

MedStar Harbor Hospital

3001 S Hanover St,
Baltimore, MD 21225

MedStar Health Bel Air Medical Campus

12 Medstar Blvd,
Bel Air, MD 21015 

To make an appointment call

443-777-7990,
Request an Appointment